OptimizeRx Non-GAAP EPS of $0.08 beats by $0.20, revenue of $21.9M beats by $3.21M
Source: SeekingAlpha
2025-05-12 17:03:51 ET
More on OptimizeRx
- OptimizeRx Corporation (OPRX) Q4 2024 Earnings Call Transcript
- OptimizeRx Q1 2025 Earnings Preview
- OptimizeRx beats top-line and bottom-line estimates; initiates FY25 outlook
- Seeking Alpha’s Quant Rating on OptimizeRx
- Historical earnings data for OptimizeRx
Read the full article on Seeking Alpha
For further details see:
OptimizeRx Non-GAAP EPS of $0.08 beats by $0.20, revenue of $21.9M beats by $3.21M
OptimizeRx Corporation
NASDAQ: OPRX
OPRX Trading
0.65% G/L:
$6.15 Last:
311,923 Volume:
$6.01 Open:
OPRX Latest News
March 05, 2026 05:04:30 pm
UPDATE - OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
March 05, 2026 04:01:00 pm
OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results
OPRX Stock Data
$189,855,041
17,596,775
3.29%
31
N/A
Healthcare Providers & Services
Healthcare
US
Waltham
